Maverick Capital’s Gilead Sciences GILD Stock Holding History

Maverick Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,370	Closed	-$604K	–	768
2020 Q4	$604K	Sell	10,370 -35,010	-77%	-$2.11M	0.01%	331
2020 Q3	$2.87M	Buy	+45,380	New	+$3.15M	0.05%	98
2020 Q1	–	Sell	-25,365	Closed	-$1.65M	–	494
2019 Q4	$1.65M	Buy	25,365 +9,205	+57%	+$599K	0.02%	286
2019 Q3	$1.02M	Buy	+16,160	New	+$1.06M	0.02%	276
2017 Q3	–	Sell	-24,760	Closed	-$1.75M	–	202
2017 Q2	$1.75M	Buy	24,760 +15,300	+162%	+$1.02M	0.02%	151
2017 Q1	$643K	Buy	9,460 +940	+11%	+$66.1K	0.01%	122
2016 Q4	$610K	Buy	8,520 +640	+8%	+$47.6K	0.01%	120
2016 Q3	$623K	Buy	7,880 +860	+12%	+$69.9K	0.01%	116
2016 Q2	$586K	Buy	7,020 +1,390	+25%	+$123K	0.01%	121
2016 Q1	$517K	Buy	5,630 +3,290	+141%	+$297K	0.01%	114
2015 Q4	$237K	Hold	2,340	–	–	﹤0.01%	117
2015 Q3	$230K	Hold	2,340	–	–	﹤0.01%	111
2015 Q2	$274K	Sell	2,340 -310	-12%	-$33.9K	﹤0.01%	66
2015 Q1	$260K	Buy	+2,650	New	+$269K	﹤0.01%	90

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Maverick Capital's GILD Position: Q1 2021 in Review

Maverick Capital sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 10,370 shares — an estimated $604K sold.

Maverick Capital first reported a position in GILD in Q1 2015 and held it in 14 quarters. The position peaked at $2.87M in Q3 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

Maverick Capital reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
Maverick Capital sold 10,370 Gilead Sciences shares in Q1 2021, an estimated $604K.
Maverick Capital first reported a position in Gilead Sciences in Q1 2015 and held it in 14 quarters.
Maverick Capital's Gilead Sciences position peaked at $2.87M in Q3 2020.
1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Maverick Capital's 13F filing for Q1 2021, filed 17 May 2021.